Melvin H Freedman
Freedman, Melvin H.
Freedman, Melvin H. (Melvin Harris)
VIAF ID: 114257462 (Personal)
Permalink: http://viaf.org/viaf/114257462
Preferred Forms
- 100 1 0 ‡a Freedman, Melvin H.
- 100 1 _ ‡a Freedman, Melvin H.
- 100 1 _ ‡a Freedman, Melvin H. ‡q (Melvin Harris) (sparse)
- 100 0 _ ‡a Melvin H Freedman
4xx's: Alternate Name Forms (1)
Works
Title | Sources |
---|---|
Clinical disorders and experimental models of erythropoietic failure, c1993: | |
Clinical utility of marrow cell tissue cultures in acute leukemia of childhood | |
Clostridium septicum myonecrosis in congenital neutropenia. | |
Comparison of deferoxamine pharmacokinetics between asymptomatic thalassemic children and those exhibiting severe neurotoxicity | |
Comparison of DR5 and Fas expression levels relative to the chemosensitivity of acute lymphoblastic leukemia cell lines | |
Comparison of oral iron chelator L1 and desferrioxamine in iron-loaded patients | |
Congenital amegakaryocytic thrombocytopenia: an intrinsic hematopoietic stem cell defect. | |
Constitutional aplastic anaemia: defective haematopoietic stem cell growth in vitro | |
Deferoxamine: a reversible S-phase inhibitor of human lymphocyte proliferation | |
Diamond-Blackfan syndrome: evidence against cell-mediated erythropoietic suppression | |
Diamond-Blackfan syndrome. II. In vitro corticosteroid effect on erythropoiesis. | |
Differences in cell cycle kinetics of candidate engrafting cells in human bone marrow and mobilized peripheral blood | |
Disease progression in recently diagnosed patients with inherited marrow failure syndromes: a Canadian Inherited Marrow Failure Registry (CIMFR) report. | |
Effect of age at the start of iron chelation therapy on gonadal function in beta-thalassemia major | |
Effect of deferoxamine on DNA synthesis, DNA repair, cell proliferation, and differentiation of HL-60 cells | |
The evolution of juvenile myelomonocytic leukemia in a female patient with paternally inherited neurofibromatosis type 1 | |
Factors affecting erythroid colony growth (CFU-E) from human marrow | |
Growth Failure and Bony Changes Induced by Deferoxamine | |
Growth inhibitory effect of gene-cloned interferons on human myeloblast colonies | |
Growth requirements for human acute lymphoblastic leukemia cells: refinement of a clonogenic assay | |
Hematopoiesis in the human spleen | |
Hodgkin's disease in children: treatment with MOPP and low-dose, extended field irradiation without laparotomy. Late results and toxicity | |
How to enjoy this moment, 1982 | |
An improved limited sampling method for individualised busulphan dosing in bone marrow transplantation in children | |
Improved survival in severe acquired aplastic anemia of childhood | |
In vitro and in vivo effects of deferoxamine in neonatal acute leukemia | |
The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy | |
Induction of differentiation in HL-60 promyelocytic cells: a comparative study in two sublines. | |
Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor | |
Juvenile chronic myelogenous leukemia: differentiation from infantile cytomegalovirus infection | |
Lessons learned from a privacy breach at an academic health science centre | |
Letter: Primary thrombocythemia in a child | |
Malignant hematological disorders in children with Wolf–Hirschhorn syndrome | |
Malignant myeloid transformation in congenital forms of neutropenia. | |
Mastocytosis cells bearing a c-kit activating point mutation are characterized by hypersensitivity to stem cell factor and increased apoptosis | |
Modulation of human hematopoiesis by prostaglandins and lithium | |
Mutant p53 in bone marrow stromal cells increases VEGF expression and supports leukemia cell growth | |
Mutation analysis of SBDS in pediatric acute myeloblastic leukemia. | |
A new frameshift β°-thalassemia mutation (codons 27–28 +C) found in a Chinese family | |
Novel point mutation in the extracellular domain of the granulocyte colony-stimulating factor (G-CSF) receptor in a case of severe congenital neutropenia hyporesponsive to G-CSF treatment. | |
A practical, comprehensive classification for pediatric myelodysplastic syndromes: the CCC system. | |
Pulmonary syndrome in patients with thalassemia major receiving intravenous deferoxamine infusions | |
Purine nucleoside phosphorylase deficiency associated with a dysplastic marrow morphology | |
Rarity of systemic lupus erythematosus after oral iron chelator L1 | |
Recombinant human granulocyte colony-stimulating factor therapy for patients with neutropenia and/or neutrophil dysfunction secondary to glycogen storage disease type 1b. | |
Recombinant human interferon alpha-2 and juvenile chronic myelogenous leukemia: cell receptor binding, enzymatic induction, and growth suppression in vitro | |
The regulatory role of interleukin 2-responsive T lymphocytes on human marrow granulopoiesis | |
Reply to Hasle et al | |
Residual juvenile chronic myelogenous leukemia cells detected in peripheral blood during clinical remission | |
Ribonuclease inhibition of erythropoiesis in anemia of uremia | |
Risk of myelodysplastic syndrome and acute myeloid leukemia in congenital neutropenias | |
Separation of lymphoid and myeloid blasts in the mixed blast crisis of chronic myelogenous leukemia: no evidence for Ig gene rearrangement in CALLA-positive blasts | |
Serial studies of auditory neurotoxicity in patients receiving deferoxamine therapy | |
The Severe Chronic Neutropenia International Registry: 10-Year Follow-up Report | |
Shwachman-diamond syndrome. | |
Shwachman syndrome: phenotypic manifestations of sibling sets and isolated cases in a large patient cohort are similar | |
Single-centre experience with allogeneic bone marrow transplantation for acute lymphoblastic leukaemia in childhood: similar survival after matched-related and matched-unrelated donor transplants | |
Studies of the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one in thalassemia patients | |
Sustained cyclosporine-induced erythropoietic response in identical male twins with diamond-blackfan anemia | |
Synergistic antiproliferative effects on HL-60 cells: deferoxamine enhances cytosine arabinoside, methotrexate, and daunorubicin cytotoxicity | |
Telomere shortening in leucocyte subsets of long-term survivors of allogeneic bone marrow transplantation | |
Telomeres, X-inactivation ratios, and hematopoietic stem cell transplantation in humans: a review | |
Thrombocytopenia with absent radii: frequency of marrow megakaryocyte progenitors, proliferative characteristics, and megakaryocyte growth and development factor responsiveness | |
Transient myelodysplastic syndrome associated with isochromosome 7q abnormality | |
Trial of recombinant human erythropoietin: three patients with thalassemia intermedia | |
Unexpected complications after bone marrow transplantation in transfusion-dependent children | |
The utility of plasma polymerase chain reaction for human herpes virus-6 among pediatric bone marrow transplant recipients: results of a pilot study | |
A variant form of Bernard-Soulier syndrome: mild haemostatic defect associated with partial platelet GPIb deficiency |